BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 10, 2020

View Archived Issues

Autophagy linked to neurotransmission

Read More

A promising multitarget antipsychotic among piperidine-amide substituted derivatives

Read More

Immuron reports new data on vaccine targeting Campylobacter and ETEC

Read More

Arcturus reports interim data from phase I/II study of COVID-19 vaccine candidate ARCT-021

Read More

Gilead Sciences patents HIV protease inhibitors

Read More

Aligos Therapeutics divulges new compounds for hepatitis

Read More

Vivace Therapeutics synthesizes YAP1/TEAD interaction inhibitors

Read More

LIfT BioSciences reports in vivo data on N-LIfT for pancreatic cancer

Read More

GBiotech Sarl presents new FFAR1 agonists

Read More

Chinese researchers discover EpCAM-targeting antibodies

Read More

hAd5-COVID-19 stimulates memory T-cell recall in previously infected COVID-19 patients

Read More

First patient dosed in phase I study of NTLA-2001 in hATTR-PN

Read More

Researchers develop a new Ptpn14-knockout murine model of HHT

Read More

European Commission approves Calquence for the treatment of CLL

Read More

Study shows how mutant KRAS initiates pancreatic cancer

Read More

Preclinical characterization of [99mTc]Tc-TECANT-1

Read More

[125I]PIB-Ec1 as promising tracer for imaging EpCAM expression in ovarian cancer

Read More

Phase III NAVIGATOR study of tezepelumab in severe asthma meets primary endpoint

Read More

GlaxoSmithKline's RSVPreF3 candidate vaccine shows promising clinical results

Read More

Arena reports topline phase IIb results with etrasimod in atopic dermatitis

Read More

New phase Ib/IIa trial examines Immunophotonics' IP-001 in thermally ablated solid tumors

Read More

FDA issues EUA for Lilly's bamlanivimab to treat recently diagnosed COVID-19

Read More

Phase I/II data with PKU gene therapy HMI-102 show marked reductions in Phe at two doses

Read More

Phase III CARDINAL study of bardoxolone in Alport syndrome meets primary endpoint

Read More

FDA approves Totect to treat cardiomyopathy in women receiving doxorubicin for breast cancer

Read More

Sorrento files IND for STI-2020 for treatment of COVID-19

Read More

FDA issues complete response letter for SPN-812 for ADHD

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 9, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 3, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing